Hepatic steatosis is defined as pathologically elevated liver fat content and has many
underlying causes. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with an estimated prevalence of up to 30% in the general population and higher …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Quantitative imaging biomarkers of liver disease measured by using MRI and US are
emerging as important clinical tools in the management of patients with chronic liver disease …

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …

Hepatic steatosis without specific causes (eg, viral infection, alcohol abuse, etc.) is called
non-alcoholic fatty liver disease (NAFLD), which ranges from non-alcoholic fatty liver (NAFL) …

Excessive intracellular accumulation of triglycerides in the liver, or hepatic steatosis, is a
highly prevalent condition affecting approximately one billion people worldwide. In the …

Fatty liver disease has a high and increasing prevalence worldwide, is associated with
adverse cardiovascular events and higher long-term medical costs, and may lead to liver …

Nonalcoholic fatty liver disease, characterized by excessive accumulation of fat in the liver,
is the most common chronic liver disease worldwide. The current standard for the detection …

The study of ultrasound tissue interactions in fatty livers has a long history with strong clinical
potential for assessing steatosis. Recently we proposed alternative measures of first-and …